Assessment of Regional Lung Function with Multivolume (1)H MR Imaging in Health and Obstructive Lung Disease: Comparison with (3)He MR Imaging.

Purpose To introduce a method based on multivolume proton (hydrogen [(1)H]) magnetic resonance (MR) imaging for the regional assessment of lung ventilatory function, investigating its use in healthy volunteers and patients with obstructive lung disease and comparing the outcome with the outcome of the research standard helium 3 ((3)He) MR imaging. Materials and Methods The institutional review board approved the HIPAA-compliant protocol, and informed written consent was obtained from each subject. Twenty-six subjects, including healthy volunteers (n = 6) and patients with severe asthma (n = 11) and mild (n = 6) and severe (n = 3) emphysema, were imaged with a 1.5-T whole-body MR unit at four lung volumes (residual volume [RV], functional residual capacity [FRC], 1 L above FRC [FRC+1 L], total lung capacity [TLC]) with breath holds of 10-11 seconds, by using volumetric interpolated breath-hold examination. Each pair of volumes were registered, resulting in maps of (1)H signal change between the two lung volumes. (3)He MR imaging was performed at FRC+1 L by using a two-dimensional gradient-echo sequence. (1)H signal change and (3)He signal were measured and compared in corresponding regions of interest selected in ventral, intermediate, and dorsal areas. Results In all volunteers and patients combined, proton signal difference between TLC and RV correlated positively with (3)He signal (correlation coefficient R(2) = 0.64, P < .001). Lower (P < .001) but positive correlation results from (1)H signal difference between FRC and FRC+1 L (R(2) = 0.44, P < .001). In healthy volunteers, (1)H signal changes show a higher median and interquartile range compared with patients with obstructive disease and significant differences between nondependent and dependent regions. Conclusion Findings in this study demonstrate that multivolume (1)H MR imaging, without contrast material, can be used as a biomarker for regional ventilation, both in healthy volunteers and patients with obstructive lung disease. © RSNA, 2014.